{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:11:56Z","timestamp":1790169116830,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The shiga toxin-producing <jats:italic>E. coli<\/jats:italic> (STEC) O104:H4 caused a major outbreak in Germany in spring 2011. STEC are usually susceptible to common antibiotics. However, antibiotic treatment of STEC-infected patients is not recommended because STEC may enhance production and release of shiga toxins (STX) in response to antibiotics, which eventually enhances the frequency and severity of clinical symptoms, including haemolytic uraemic syndrome (HUS) and fatalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We characterized the response to antibiotics of STEC O104:H4 isolates from two HUS patients during the German STEC outbreak in spring 2011 in comparison to the common STEC O157:H7. Liquid cultures of STEC O157:H7 and O104:H4 were incubated with graded dilutions of the antibiotics ciprofloxacin, meropenem, fosfomycin, gentamicin, rifampicin, and chloramphenicol. At defined times of antibiotic treatment, transcriptional activation of the STX2 gene, contents of STX and STX-activity in the culture supernatants were quantified. Unlike the common serotype O157:H7, STEC O104:H4 does not release STX in response to therapeutic concentrations of ciprofloxacin, meropenem, fosfomycin, and chloramphenicol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In future outbreaks, the response of the respective epidemiologic STEC strain to antibiotics should be rapidly characterized in order to identify antibiotics that do not enhance the release of STX. This will eventually allow clinical studies tackling the question whether antibiotic treatment impacts on the eradication of STEC, clinical course of disease, and frequency of carriers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2180-12-160","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T14:14:43Z","timestamp":1343830483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak"],"prefix":"10.1186","volume":"12","author":[{"given":"Diana","family":"Corogeanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Willmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Wolke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Plum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Uterm\u00f6hlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kr\u00f6nke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"key":"1692_CR1","volume-title":"Report: Final presentation and evaluation of epidemiological findings in the EHEC O104:H4 outbreak, Germany 2011","author":"Robert Koch Institute","year":"2011","unstructured":"Robert Koch Institute: Report: Final presentation and evaluation of epidemiological findings in the EHEC O104:H4 outbreak, Germany 2011. 2011, , Berlin, www.rki.de"},{"issue":"1","key":"1692_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MOG.0b013e3282f2dfb8","volume":"24","author":"A Serna","year":"2008","unstructured":"Serna A, Boedeker EC: Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol. 2008, 24 (1): 38-47. 10.1097\/MOG.0b013e3282f2dfb8.","journal-title":"Curr Opin Gastroenterol"},{"issue":"11","key":"1692_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s100960050181","volume":"17","author":"K Grif","year":"1998","unstructured":"Grif K, Dierich MP, Karch H, Allerberger F: Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis. 1998, 17 (11): 761-766. 10.1007\/s100960050181.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1692_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF01704889","volume":"20","author":"JN Walterspiel","year":"1992","unstructured":"Walterspiel JN, Ashkenazi S, Morrow AL, Cleary TG: Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection. 1992, 20 (1): 25-29. 10.1007\/BF01704889.","journal-title":"Infection"},{"issue":"5","key":"1692_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00001432-200410000-00013","volume":"17","author":"AA MacConnachie","year":"2004","unstructured":"MacConnachie AA, Todd WT: Potential therapeutic agents for the prevention and treatment of haemolytic uraemic syndrome in shiga toxin producing Escherichia coli infection. Curr Opin Infect Dis. 2004, 17 (5): 479-482. 10.1097\/00001432-200410000-00013.","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"1692_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1056\/NEJM198303243081203","volume":"308","author":"LW Riley","year":"1983","unstructured":"Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, et al: Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med. 1983, 308 (12): 681-685. 10.1056\/NEJM198303243081203.","journal-title":"N Engl J Med"},{"issue":"4","key":"1692_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.mib.2005.06.001","volume":"8","author":"MK Waldor","year":"2005","unstructured":"Waldor MK, Friedman DI: Phage regulatory circuits and virulence gene expression. Curr Opin Microbiol. 2005, 8 (4): 459-465. 10.1016\/j.mib.2005.06.001.","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"1692_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1086\/322598","volume":"33","author":"S Dundas","year":"2001","unstructured":"Dundas S, Todd WT, Stewart AI, Murdoch PS, Chaudhuri AK, Hutchinson SJ: The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis. 2001, 33 (7): 923-931. 10.1086\/322598.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1692_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S0950268897007541","volume":"119","author":"M Yoh","year":"1997","unstructured":"Yoh M, Honda T: The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production\/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro. Epidemiol Infect. 1997, 119 (1): 101-103. 10.1017\/S0950268897007541.","journal-title":"Epidemiol Infect"},{"issue":"9","key":"1692_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1473-3099(11)70165-7","volume":"11","author":"Bielaszewska M, Mellmann A, Zhang W, Kock R, Fruth A, Bauwens A, Peters G, Karch H: Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany","year":"2011","unstructured":"Bielaszewska M, Mellmann A, Zhang W, Kock R, Fruth A, Bauwens A, Peters G, Karch H: Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany: a microbiological study. Lancet Infect Dis. 2011, 11 (9): 671-676.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1692_CR11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/iai.53.1.135-140.1986","volume":"53","author":"NA Strockbine","year":"1986","unstructured":"Strockbine NA, Marques LR, Newland JW, Smith HW, Holmes RK, O'Brien AD: Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun. 1986, 53 (1): 135-140.","journal-title":"Infect Immun"},{"issue":"3","key":"1692_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/AAC.34.3.481","volume":"34","author":"B Brismar","year":"1990","unstructured":"Brismar B, Edlund C, Malmborg AS, Nord CE: Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother. 1990, 34 (3): 481-483. 10.1128\/AAC.34.3.481.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"1692_CR13","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1093\/clinids\/24.Supplement_2.S181","volume":"24","author":"RE Condon","year":"1997","unstructured":"Condon RE, Walker AP, Hanna CB, Greenberg RN, Broom A, Pitkin D: Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgery. Clin Infect Dis. 1997, 24 (Suppl 2): S181-S183.","journal-title":"Clin Infect Dis"},{"issue":"26","key":"1692_CR14","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","volume":"342","author":"CS Wong","year":"2000","unstructured":"Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI: The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000, 342 (26): 1930-1936. 10.1056\/NEJM200006293422601.","journal-title":"N Engl J Med"},{"issue":"8","key":"1692_CR15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jama.288.8.996","volume":"288","author":"N Safdar","year":"2002","unstructured":"Safdar N, Said A, Gangnon RE, Maki DG: Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. Jama. 2002, 288 (8): 996-1001. 10.1001\/jama.288.8.996.","journal-title":"Jama"},{"issue":"17","key":"1692_CR16","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJM199010253231703","volume":"323","author":"DL Martin","year":"1990","unstructured":"Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT: The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med. 1990, 323 (17): 1161-1167. 10.1056\/NEJM199010253231703.","journal-title":"N Engl J Med"},{"issue":"1","key":"1692_CR17","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1542\/peds.100.1.e12","volume":"100","author":"BP Bell","year":"1997","unstructured":"Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI: Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics. 1997, 100 (1): E12-10.1542\/peds.100.1.e12.","journal-title":"Pediatrics"},{"issue":"6","key":"1692_CR18","first-page":"357","volume":"52","author":"K Ikeda","year":"1999","unstructured":"Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K: Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol. 1999, 52 (6): 357-362.","journal-title":"Clin Nephrol"},{"issue":"8","key":"1692_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s100960050348","volume":"18","author":"T Kurioka","year":"1999","unstructured":"Kurioka T, Yunou Y, Harada H, Kita E: Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition. Eur J Clin Microbiol Infect Dis. 1999, 18 (8): 561-571. 10.1007\/s100960050348.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"1692_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijantimicag.2010.10.009","volume":"37","author":"EA Rahal","year":"2011","unstructured":"Rahal EA, Kazzi N, Kanbar A, Abdelnoor AM, Matar GM: Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB\/c mice. Int J Antimicrob Agents. 2011, 37 (2): 135-139. 10.1016\/j.ijantimicag.2010.10.009.","journal-title":"Int J Antimicrob Agents"},{"key":"1692_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1476-0711-10-34","volume":"10","author":"EA Rahal","year":"2011","unstructured":"Rahal EA, Kazzi N, Sabra A, Abdelnoor AM, Matar GM: Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB\/c mice. Ann Clin Microbiol Antimicrob. 2011, 10: 34-10.1186\/1476-0711-10-34.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"1692_CR22","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1128\/AAC.06315-11","volume":"56","author":"M Bielaszewska","year":"2012","unstructured":"Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, Peters G, Karch H: Epidemic Escherichia coli O104:H4: Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction. Antimicrob Agents Chemother. 2012, 56 (6): 3277-3282. 10.1128\/AAC.06315-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1692_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/mcpr.1999.0251","volume":"13","author":"VK Sharma","year":"1999","unstructured":"Sharma VK, Dean-Nystrom EA, Casey TA: Semi-automated fluorogenic PCR assays (TaqMan) forrapid detection of Escherichia coli O157:H7 and other shiga toxigenic E. coli. Mol Cell Probes. 1999, 13 (4): 291-302. 10.1006\/mcpr.1999.0251.","journal-title":"Mol Cell Probes"},{"issue":"3","key":"1692_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/jcm.12.3.361-366.1980","volume":"12","author":"MK Gentry","year":"1980","unstructured":"Gentry MK, Dalrymple JM: Quantitative microtiter cytotoxicity assay for Shigella toxin. J Clin Microbiol. 1980, 12 (3): 361-366.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2180-12-160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:39:04Z","timestamp":1630525144000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/1471-2180-12-160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1186\/1471-2180-12-160","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,1]]},"assertion":[{"value":"28 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"160"}}